Day One Biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. We are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. Our distinctive approach, together with our trusted network of pediatric oncology investigators, gives us an unparalleled ability to advance promising discoveries for patients of any age. We are ready to pursue the full potential of our therapies to improve the greatest number of lives as quickly as possible.
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $362.5M
Founded date: 2018
Investors 5
Date | Name | Website |
20.02.2021 | Logos Capi... | logoscapit... |
- | Access Bio... | accessbio-... |
- | RA Capital... | racap.com |
- | Atlas Vent... | atlasventu... |
- | Canaan Par... | canaan.com |
Funding Rounds 3
Date | Series | Amount | Investors | Deal News |
13.06.2022 | - | $172.5M | - | - |
11.02.2021 | Series B | $130M | - | pitchbook.... |
22.05.2020 | Series A | $60M | - | canaan.com... |
Mentions in press and media 14
Date | Title | Description | Source |
30.10.2023 | Your Monday morning biotech news roundup | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
01.05.2023 | Day One Reports First Quarter 2023 Financial Results and Cor... | /EIN News/ -- FIREFLY-1 clinical abstract selected for oral presentation at the 2023 American Societ... | einpresswi... |
06.03.2023 | Day One Reports Fourth Quarter and Full Year 2022 Financial ... | /EIN News/ -- First patient dosed in pivotal Phase 3 FIREFLY-2/LOGGIC trial evaluating tovorafenib (... | einpresswi... |
13.06.2022 | In early trial, drug shrinks tumors in majority of children ... | Day One Biopharmaceuticals reported Sunday that an experimental molecule shrank tumors by at least 5... | statnews.c... |
01.09.2021 | Dayone Capital Fund I Closes at USD630 million with Oversubs... | SHENZHEN, China, Sept. 1, 2021 /PRNewswire/ -- Dayone Capital announced today the final closing of... | prnewswire... |
01.09.2021 | Dayone Capital Closes Fund I, at USD630 M | Dayone Capital Logo Dayone Capital, a Shenzen, China-based private equity firm, closed Dayone Capit... | finsmes.co... |
11.02.2021 | Timmerman Report: No longer an afterthought -- Day One raise... | - | canaan.com... |
11.02.2021 | SF Business Times: Targeting more childhood cancers, Day One... | - | canaan.com... |
11.02.2021 | Day One Biopharmaceuticals Inks $130M Series B Financing | SAN FRANCISCO, CA, Day One Biopharmaceuticals announced a $130 million Series B financing from lea... | vcnewsdail... |
11.02.2021 | Day One Biopharmaceuticals picks up $130M | Day One Biopharmaceuticals has raised a $130 million Series B led by RA Capital Management. The comp... | pitchbook.... |
Show more